Biomarkers of acute myocardial infarction: diagnostic and prognostic value. Part 2 (Literature review)

Abstract

In the second part of the review, we continue the discussion of biomarkers that have a diagnostic and prognostic significance in acute myocardial infarction (AMI). The study of the AMI pathophysiology through the experimental and clinical research contributes to the discovery of new regulatory molecules and pathogenetic mechanisms underlying AMI. At the same time, many molecules involved in the pathogenesis of AMI can be used as effective biomarkers for the diagnosis and prediction of AMI. This article discusses in detail the diagnostic and prognostic value of inflammatory biomarkers of AMI (C-reactive protein, interleukin-6, tumor necrosis factor-alpha, myeloperoxidase, matrix metalloproteinases, soluble form of CD40 ligand, procalcitonin, placental growth factor) and a number of recently discovered new biomarkers of AMI (microribonucleic acids, galectin-3, stimulating growth factor expressed by gene 2, growth differentiation factor 15, proprotein convertase of subtilisin-kexin type 9).

Keywords

laboratory diagnostics / acute myocardial infarction / AMI / biomarkers / C-reactive protein / interleukin-6 / tumor necrosis factor-alpha / myeloperoxidase / matrix metalloproteinases / procalcitonin / microribonucleic acids / galectin-3 / proprotein convertase subtilisin-Kexin type 9

RIGHTS & PERMISSIONS

Chaulin A.M., Duplyakov D.V.